Download full-text PDF

Source

Publication Analysis

Top Keywords

iodine-131 accumulation
4
accumulation pericardial
4
pericardial effusion
4
iodine-131
1
pericardial
1
effusion
1

Similar Publications

Direct Labeling of Gold Nanoparticles with Iodine-131 for Tumor Radionuclide Therapy.

Int J Nanomedicine

November 2024

Department of Nuclear Medicine, Northern Jiangsu People's Hospital, Clinical Medical College, Yangzhou University, Yangzhou, 225001, People's Republic of China.

Article Synopsis
  • Gold nanoparticles (Au NPs) can be easily labeled with radioactive iodine, making them promising tools for tumor treatment and diagnosis in cancer therapy.
  • This study evaluated the stability and effectiveness of iodine-adsorbed Au NPs in targeting tumors, using various conditions to analyze their performance.
  • The results indicate that these iodine-adsorbed Au NPs are stable, effective in inhibiting tumor cells, and show therapeutic potential when injected into tumors in living subjects.
View Article and Find Full Text PDF

Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice.

Int J Mol Sci

October 2024

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

Article Synopsis
  • Preliminary research found that a radioactive antibody called [I]I-ERIC1 specifically targets neuroblastoma tumor cells in mice, showing significant accumulation in tumors.
  • Researchers aimed to assess the safety and effectiveness of this antibody in treating neuroblastoma by testing various doses on healthy and tumor-bearing mice.
  • Results indicated that the optimal dose for treatment was between 1.8-2.5 MBq per animal, which improved survival rates significantly while ensuring minimal side effects at lower doses.
View Article and Find Full Text PDF

This study evaluates the efficacy of [I]I-ERIC1 in targeting and inhibiting the growth of SCLC tumors in mice, focusing on tumor accumulation and regression and potential side effects. NCAM-positive NCI-H69 SCLC cells were implanted in CB 17 SCID mice, and [I]I-ERIC1 biokinetics were measured in organs and tissues at four post-injection time points (24, 72, 96, and 120 h). The experimental series compared tumor growth, survival, and changes in blood counts among three treatment groups (1, 2, or 3 MBq) and a control group, with treatments initiated either two or five days post implantation.

View Article and Find Full Text PDF
Article Synopsis
  • * Contamination sources include air, food, and water, making proximity to nuclear incidents a significant factor in exposure risk, especially in iodine-deficient areas.
  • * To mitigate these risks, ensuring sufficient iodine supply is vital, and the use of potassium iodide tablets can protect the thyroid by blocking radioactive iodine absorption, but this protection is time-sensitive and mainly recommended for individuals under 40.
View Article and Find Full Text PDF

Responsive and traceless assembly of iron nanoparticles and I labeled radiopharmaceuticals for ferroptosis enhanced radio-immunotherapy.

Biomaterials

February 2025

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. Electronic address:

Ferroptosis is an iron-dependent form of programmed cell death with the potential to reverse traditional cancer therapy resistance. The combination of ferroptosis with chemotherapy, photodynamic therapy and X-ray therapy has demonstrated remarkably improved therapeutic efficiency. Radiopharmaceutical therapy (RPT) is an emerging approach that achieves precise radiation to diseased tissues via radionuclide delivery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!